Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Mallinckrodt's INOmax™ (Nitric Oxide) Gas, for Inhalation, Approved in Australia for Pulmonary Hypertension in Adults in Conjunction with Cardiovascular Surgery 2019-04-11 05:00
Dr Gillies O'Bryan-Tear Joins Clarity Pharmaceuticals' Board 2019-04-10 09:30
Antengene Corporation Announces Establishment of U.S. Subsidiary and Collaboration with the Baruch S. Blumberg Institute 2019-04-08 20:00
CStone Pharmaceuticals presented poster of pre-clinical result for CS1003 at AACR 2019-04-04 23:44
China SXT Pharmaceuticals, Inc. Receives National High-tech Enterprise Qualification 2019-04-02 18:30
Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50 mg 2019-03-30 04:06
Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval 2019-03-29 11:48
Transcenta Holding Announces Licensing Agreement with Lilly 2019-03-29 08:30
China SXT Pharmaceuticals, Inc. Announces Financial Results for the Six Months Ended September 30, 2018 2019-03-28 18:30
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection 2019-03-27 14:00
GCAM Adds New Plasma Collection Center 2019-03-26 12:05
Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board 2019-03-26 08:30
CStone appoints three distinguished oncology leaders Drs. Paul A. Bunn, Jr., Elizabeth M. Jaffee and Richard S. Finn to its Scientific Advisory Board 2019-03-25 15:14
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009) 2019-03-21 21:32
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials 2019-03-21 18:21
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row 2019-03-21 13:42
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:20
WuXi Biologics Receives EMA GMP Certificates 2019-03-20 08:07
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma 2019-03-20 05:05
I-Mab Biopharma Announces Dosing of First Subject in Phase 1 Clinical Trial of Anti-GM-CSF Monoclonal Antibody TJM2 in the United States 2019-03-19 18:00
1 131 132 133 134 135 165